Paul Tudor Jones Deciphera Pharmaceuticals, Inc. Transaction History

Tudor Investment Corp Et Al

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $536,749 - $686,154	39,525 New	39,525 $621,000
Q3 2023 Nov 15, 2023	BUY	$12.46 - $15.48 $526,285 - $653,844	42,238 New	42,238 $537,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $410,855 - $671,373	33,187 New	33,187 $614,000
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $447,155 - $686,194	-49,084 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $337,207 - $545,323	49,084 New	49,084 $455,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $520,079 - $761,925	-15,890 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $643,856 - $904,332	-15,941 Reduced 50.08%	15,890 $713,000
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $1.65 Million - $2.11 Million	31,831 New	31,831 $1.82 Million
Q4 2017 Feb 14, 2018	SELL	$16.54 - $24.2 $870,500 - $1.27 Million	-52,630 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $928,919 - $999,443	52,630	52,630 $999,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.